Ventricular septal defect

Genetic Testing Market to Reach $28.24 Billion by 2030 - Market Size, Share, Forecasts, & Trends Analysis Report by Meticulous Research®

Retrieved on: 
Monday, March 20, 2023
Glaucoma, DNA, Ventricular septal defect, Prevalence, Impact, Viral Research and Diagnostic Laboratories, Parent, Hospital, Pharmacogenomics, COVID-19, Cancer, Down syndrome, Genetic testing, Diagnosis, Genomics, Hemoglobinopathy, Disorder, Government, PerkinElmer, Fragile X syndrome, MUFG Americas Holdings Corporation, Thermo Fisher Scientific, Patient, Laboratory, Risk, Developed country, Preimplantation genetic diagnosis, Investment, Labcorp, Consumables, Cystic fibrosis, Carrier, Hospital Clinic Manuel Quintela, Association for Molecular Pathology v. Myriad Genetics, Inc., Rare, Illumina, Inc., Geography, Pharmaceutical industry, Dietary supplement, Chromosome, Prenatal development

Genetic testing is done to look at changes in the DNA, sometimes called variants or mutations, that can lead to chronic diseases.

Key Points: 
  • Genetic testing is done to look at changes in the DNA, sometimes called variants or mutations, that can lead to chronic diseases.
  • Genetic testing is performed for different reasons, including pre-symptomatic and predictive testing, pharmacogenetics, diagnostic testing, carrier testing, prenatal testing, preimplantation testing, and newborn screening.
  • Genetic testing has applications in different areas of healthcare and has various advantages, such as determining the likelihood of parents passing the genetic mutation to their offspring.
  • Quick Buy – Genetic Testing Market Research Report: https://www.meticulousresearch.com/Checkout/33822956
    Based on end user, in 2023, the hospitals & clinics segment is expected to account for the largest share of this market.

Genetic Testing Market to Reach $28.24 Billion by 2030 - Market Size, Share, Forecasts, & Trends Analysis Report by Meticulous Research®

Retrieved on: 
Monday, March 20, 2023
Glaucoma, DNA, Ventricular septal defect, Prevalence, Impact, Viral Research and Diagnostic Laboratories, Parent, Hospital, Pharmacogenomics, COVID-19, Cancer, Down syndrome, Genetic testing, Diagnosis, Genomics, Hemoglobinopathy, Disorder, Government, PerkinElmer, Fragile X syndrome, MUFG Americas Holdings Corporation, Thermo Fisher Scientific, Patient, Laboratory, Risk, Developed country, Preimplantation genetic diagnosis, Investment, Labcorp, Consumables, Cystic fibrosis, Carrier, Hospital Clinic Manuel Quintela, Association for Molecular Pathology v. Myriad Genetics, Inc., Rare, Illumina, Inc., Geography, Pharmaceutical industry, Dietary supplement, Chromosome, Prenatal development

Genetic testing is done to look at changes in the DNA, sometimes called variants or mutations, that can lead to chronic diseases.

Key Points: 
  • Genetic testing is done to look at changes in the DNA, sometimes called variants or mutations, that can lead to chronic diseases.
  • Genetic testing is performed for different reasons, including pre-symptomatic and predictive testing, pharmacogenetics, diagnostic testing, carrier testing, prenatal testing, preimplantation testing, and newborn screening.
  • Genetic testing has applications in different areas of healthcare and has various advantages, such as determining the likelihood of parents passing the genetic mutation to their offspring.
  • Quick Buy – Genetic Testing Market Research Report: https://www.meticulousresearch.com/Checkout/33822956
    Based on end user, in 2023, the hospitals & clinics segment is expected to account for the largest share of this market.

The 10th Annual International Pediatric Feeding Disorder Conference Unites 58 prominent Feeding and Therapy experts and more than 80 authors

Retrieved on: 
Friday, March 17, 2023
CE, Loss, International, University, Life, Francine Shapiro, Ventricular septal defect, Psychiatric-mental health nurse practitioner, PLLC, International Pediatric Nephrology Association, Trauma, Feeding disorder, Research, Private practice, University of North Carolina at Pembroke, PMHNP, APRN, Grief, Publication, Patient, Child, Matter, EMDR, PFD, Fairfield University, Family, Conference, Nursing, PHOENIX

PHOENIX, March 16, 2023 /PRNewswire-PRWeb/ -- Arizona-based nonprofit Feeding Matters, the first organization in the world dedicated to advancing the system of care for pediatric feeding disorder (PFD) is proud to host the upcoming 10th annual International Pediatric Feeding Disorder Conference (IPFDC). The IPFDC 2023 will be streamed live April 13-14, 2023, with pre-conference events on April 12, and will offer the most diverse group of speakers and lightning talk authors to date. All sessions will be available on-demand through May 31, 2023.

Key Points: 
  • Arizona-based nonprofit Feeding Matters, the first organization in the world dedicated to advancing the system of care for pediatric feeding disorder (PFD) is proud to host the upcoming 10th annual International Pediatric Feeding Disorder Conference (IPFDC).
  • PHOENIX, March 16, 2023 /PRNewswire-PRWeb/ -- Arizona-based nonprofit Feeding Matters, the first organization in the world dedicated to advancing the system of care for pediatric feeding disorder (PFD) is proud to host the upcoming 10th annual International Pediatric Feeding Disorder Conference (IPFDC).
  • This year's conference will bring together a lineup of the pediatric feeding community's foremost experts, leaders, and contributors.
  • To secure your registration or see the complete schedule with session descriptions for the year's most prolific and informative pediatric feeding conference, visit International Pediatric Feeding Disorder Conference.

Agape Care Group Announces Partnership Between Pediatric Program Hands of Hope and the Emerson Rose Heart Foundation During American Heart Month

Retrieved on: 
Thursday, February 16, 2023
Managed Care, Philanthropy, Family, Consumer, Fund Raising, Teens, Foundation, Children, Cardiology, Baby, Maternity, Religion, Other Philanthropy, Health, Terminal, Organization, Homeland security, American Heart Month, Patient, CHD, Birth defect, Research, Child, Death, Ventricular septal defect, Palliative care, Partnership, Love, Pharmaceutical industry, Nursing, Hope

Agape Care Group (Agape Care), a leading hospice and palliative care provider in the Southeast, announced that their pediatric program, Hands of Hope , is partnering with the Emerson Rose Heart Foundation , an organization that raises support, awareness and funds for those affected by congenital heart defects (CHDs).

Key Points: 
  • Agape Care Group (Agape Care), a leading hospice and palliative care provider in the Southeast, announced that their pediatric program, Hands of Hope , is partnering with the Emerson Rose Heart Foundation , an organization that raises support, awareness and funds for those affected by congenital heart defects (CHDs).
  • Hands of Hope will sponsor multiple events throughout 2023 with the Emerson Rose Heart Foundation, including charity baseball games, an event with Denver Downs Farm and a donor gala in December.
  • They will also serve as a Heart Month Matching Sponsor in recognition of American Heart Month in February.
  • The Emerson Rose Heart Foundation was named after the daughter of Jason and Susan Smith who was born with a complex CHD.

Hypertrophic Cardiomyopathy Association (HCMA) Hosts Free Webinar, Advocates for Legislation in Honor of HCM Awareness Day on February 22

Retrieved on: 
Friday, February 17, 2023
Well, Bristol Myers Squibb, Legislation, Patient, Cardiology, News, Risk, Movement, Ventricular septal defect, HCMA, HCM, Hypertrophic cardiomyopathy, EST, Pharmaceutical industry, BioMarin Pharmaceutical

DENVILLE, N.J., Feb. 17, 2023 /PRNewswire/ -- Hypertrophic Cardiomyopathy Association (HCMA), a 501(c)3 organization committed to improving the lives of those touched by hypertrophic cardiomyopathy (HCM), is honoring HCM Awareness Day on February 22 by hosting a grassroots live digital legislative advocacy event to encourage state legislative adoption of the Healthy Cardiac Monitoring Act (HCM Act). Available through the organization's website, the two live stream sessions will take place from 11:30 a.m. - 2:30 p.m. EST and from 6:30 p.m. - 8:45 p.m. EST, where viewers can hear from medical experts, patients and families affected by the most common genetic heart disorder.

Key Points: 
  • DENVILLE, N.J., Feb. 17, 2023 /PRNewswire/ -- Hypertrophic Cardiomyopathy Association (HCMA), a 501(c)3 organization committed to improving the lives of those touched by hypertrophic cardiomyopathy (HCM), is honoring HCM Awareness Day on February 22 by hosting a grassroots live digital legislative advocacy event to encourage state legislative adoption of the Healthy Cardiac Monitoring Act (HCM Act).
  • "Heart health is top of mind across the nation after headline after headline featuring devastating news of cardiac arrests.
  • "We encourage everyone to reach out to their state representatives with one click on our website to help the thousands of people living with undiagnosed heart conditions."
  • The online sessions are free to attend and open to anyone.

Medical Device Outsourcing Market Will Touch $273 Billion Value by 2030, Says P&S Intelligence

Retrieved on: 
Tuesday, January 31, 2023
Angina, Myocardial infarction, Developing country, Incidence, Ethics, Cardiovascular disease, CMOS, Knowledge, Maintenance, Ventricular septal defect, PACS, Medicine, Needle, Growth, Cardiology, Original equipment manufacturer, Intelligence, Atrial fibrillation, Pump, Acupuncture, Research, Risk management, Video game, Medical device

NEW YORK, Jan. 31, 2023 /PRNewswire/ -- The global medical device outsourcing market valued $112.1 billion in 2022, and this number is expected to reach $273.0 billion by 2030, advancing at a CAGR of 11.8% during 2022–2030, according to P&S Intelligence.

Key Points: 
  • NEW YORK, Jan. 31, 2023 /PRNewswire/ -- The global medical device outsourcing market valued $112.1 billion in 2022, and this number is expected to reach $273.0 billion by 2030, advancing at a CAGR of 11.8% during 2022–2030, according to P&S Intelligence.
  • Other key drivers are the constant development in the regulatory landscape, increasing elderly populace, and ballooning preference of medical device manufacturers for outsourcing processes including quality assurance, regulatory consulting, and product implementation.
  • Browse detailed report on Medical Device Outsourcing Market Growth, Share, Size and Demand Forecast Report 2030
    APAC will experience the fastest growth in the industry, at a CAGR of approximately 15%.
  • This can be credited to the increasing incidence of chronic illnesses, booming knowledge of consumers about medical device outsourcing, mounting elderly populace, increasing healthcare investment, and growing trend of medical travel.

Medical Device Outsourcing Market Will Touch $273 Billion Value by 2030, Says P&S Intelligence

Retrieved on: 
Tuesday, January 31, 2023
Angina, Myocardial infarction, Developing country, Incidence, Ethics, Cardiovascular disease, CMOS, Knowledge, Maintenance, Ventricular septal defect, PACS, Medicine, Needle, Growth, Cardiology, Original equipment manufacturer, Intelligence, Atrial fibrillation, Pump, Acupuncture, Research, Risk management, Video game, Medical device

NEW YORK, Jan. 31, 2023 /PRNewswire/ -- The global medical device outsourcing market valued $112.1 billion in 2022, and this number is expected to reach $273.0 billion by 2030, advancing at a CAGR of 11.8% during 2022–2030, according to P&S Intelligence.

Key Points: 
  • NEW YORK, Jan. 31, 2023 /PRNewswire/ -- The global medical device outsourcing market valued $112.1 billion in 2022, and this number is expected to reach $273.0 billion by 2030, advancing at a CAGR of 11.8% during 2022–2030, according to P&S Intelligence.
  • Other key drivers are the constant development in the regulatory landscape, increasing elderly populace, and ballooning preference of medical device manufacturers for outsourcing processes including quality assurance, regulatory consulting, and product implementation.
  • Browse detailed report on Medical Device Outsourcing Market Growth, Share, Size and Demand Forecast Report 2030
    APAC will experience the fastest growth in the industry, at a CAGR of approximately 15%.
  • This can be credited to the increasing incidence of chronic illnesses, booming knowledge of consumers about medical device outsourcing, mounting elderly populace, increasing healthcare investment, and growing trend of medical travel.

Cincinnati Children's Opens First-of-its-Kind Heart and Mind Wellbeing Center in United States

Retrieved on: 
Tuesday, January 24, 2023
AHA, Science, American Heart Association, Cincinnati Children's Hospital Medical Center, Diagnosis, Hope, Circulant matrix, Ventricular septal defect, Birth defect, CHD, Partnership, The American Heart Institute, Social, Research, Congenital heart defect, Heart, Acute stress disorder, Parent, Patient, Anxiety, Depression, Multimedia, Doctor of Philosophy, Mental health, Pharmaceutical industry, Nursing

CINCINNATI, Jan. 24, 2023 /PRNewswire/ -- Cincinnati Children's Hospital Medical Center is excited to announce the opening of its Heart and Mind Wellbeing Center , the first of its kind in the United States.

Key Points: 
  • CINCINNATI, Jan. 24, 2023 /PRNewswire/ -- Cincinnati Children's Hospital Medical Center is excited to announce the opening of its Heart and Mind Wellbeing Center , the first of its kind in the United States.
  • The Heart and Mind Wellbeing Center was created to provide comprehensive psychological support and mental health care tailored for families affected by Congenital Heart Disease (CHD) .
  • "Congenital heart disease can profoundly affect families emotionally," said Nadine Kasparian, PhD , psychologist and director of Cincinnati Children's Heart and Mind Wellbeing Center.
  • Research is also an integral part of the Heart and Mind Wellbeing Center, which is conducting groundbreaking research into parent mental health in conjunction with the Heart Institute's Fetal Heart Program at Cincinnati Children's.

UNIQUE UNDERGROUND 5K & 10K ‘GROUNDHOG RUN’ BENEFITING CHILDREN WITH DISABILITIES AT ABILITY KC® RETURNS THIS JANUARY FOR ITS 41ST RUN AT THE HUNT MIDWEST SUBTROPOLIS®

Retrieved on: 
Tuesday, January 17, 2023
SubTropolis, Nash, Community, Hypoplastic left heart syndrome, Parent, Child, Environment, Graham Nash David Crosby, Ventricular septal defect, Laryngomalacia, Hunting, Ability, USATF, CDC, Life, Disability, Health insurance, Toy, HLHS

The 2023 race will include a “Children’s Run” in between the standard 5K and 10K races.

Key Points: 
  • The 2023 race will include a “Children’s Run” in between the standard 5K and 10K races.
  • This untimed fun run is for children ages 0-8, in distances ranging from 50 yards to 200 yards based on their age group.
  • All proceeds from the Groundhog Run help Ability KC serve thousands of children with disabilities regardless of their family’s financial circumstances.
  • Nash and his parents will be joining the 41st Annual Groundhog Run to support other children like him receiving services at Ability KC.

How to Manage Birth Defects for a Lifetime

Retrieved on: 
Monday, January 16, 2023
Birth, Infection, Folate, Birth defect, Insurance, Parent, Mental health, Family, Quality of life, Down syndrome, Anatomical pathology, Risk, Health, Korea Disease Control and Prevention Agency, Pregnancy, Gene, Ventricular septal defect, Sport, Diabetes, Muscular dystrophy, Woman, Microsoft family features, Spina bifida, Intellectual, CDC, Prenatal care, Life, Disability, Pediatrics, Birth control

While some require minimal intervention after birth, many birth defects affect the individual, parents and families across a lifetime.

Key Points: 
  • While some require minimal intervention after birth, many birth defects affect the individual, parents and families across a lifetime.
  • Birth defects are structural changes present at birth that can affect almost any part of the body.
  • Awareness of birth defects across the lifespan helps provide affected individuals, parents and families the information they need to seek proper care.
  • Having adequate folic acid for at least one month before getting pregnant and throughout the pregnancy can prevent major birth defects.